NewAmsterdam Pharma (NAMS)
NewAmsterdam Pharma Provides Corporate Update and Reports Third Quarter Financial Results
NewAmsterdam Pharma Provides Corporate Update and Reports Third Quarter Financial Results
STRATA Skin Sciences to Report Third Quarter 2025 Financial Results on November 13, 2025 and Provide Corporate Update
Lexeo Therapeutics Reports Third Quarter 2025 Financial Results and Operational Highlights
Crescent Biopharma to Present at November Investor Conferences
Rezolute to Host Virtual Investor Event on Ersodetug Development Program
Compass Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Marker Therapeutics appoints Kathryn Penkus Corzo to Board of Directors
Minerva Neurosciences Reports Third Quarter 2025 Financial Results and Business Updates
Sonida Senior Living Announces Strategic Merger with CNL Healthcare Properties, Inc. in a Stock and Cash Transaction Valued at Approximately $1.8 Billion, Creating $3 Billion Pure-Play Senior Housing Owner-Operator
MediWound to Report Third Quarter 2025 Financial Results